Back to News
Market Impact: 0.28

Marvell vs. Micron: Which AI Chipmaker Is the Better Buy Right Now?

MUMRVLNVDAINTCMSFTAMZNGOOGLMETAAVGONFLX
Artificial IntelligenceTechnology & InnovationCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsM&A & Restructuring
Marvell vs. Micron: Which AI Chipmaker Is the Better Buy Right Now?

Marvell and Micron are both benefiting from AI-driven demand, but the article favors Marvell as the better buy. Marvell's XPU and networking business could get a boost from a new Google customer and expanded Microsoft Maia orders, while Nvidia's $2 billion investment reinforces the outlook. Micron remains strong on pricing, with DRAM prices up about 66% sequentially and margins at 75%, but the article warns the memory cycle is nearing an eventual oversupply-driven downturn despite EPS rising from $57.95 this year to $101.07 in two years.

Analysis

The real takeaway is that this is no longer a simple AI semiconductor trade; it is becoming a bifurcation between companies exposed to scarce, still-underbuilt AI plumbing and those exposed to the eventual normalization of that scarcity. MRVL benefits from design-win optionality and ecosystem lock-in: once a hyperscaler standardizes around a custom accelerator plus interconnect stack, switching costs rise meaningfully and revenue visibility extends well beyond the first shipment. That makes MRVL less about near-term unit growth and more about capturing a larger share of an expanding system architecture. MU’s setup is stronger near term but more fragile structurally. The market is correctly pricing in a multi-quarter pricing tailwind, but it may be underestimating how much of the current earnings power is front-loaded into a window where supply is still constrained and capex discipline remains intact. The second-order risk is that the same capex wave supporting HBM margins today creates a 2028-29 oversupply trap, which usually hits the equity before it shows up in reported earnings as investors discount the next downcycle 6-12 months in advance. The consensus is probably still too linear on both names. For MU, the issue is not whether earnings go higher over the next 6-12 months — it is whether the stock is already discounting too much of the peak-cycle margin and whether multiple compression starts when capacity additions become more visible. For MRVL, the market may still be underappreciating how much incremental value comes from being the “picks and shovels” for custom silicon rather than from the accelerators themselves, especially if hyperscalers keep diversifying away from pure GPU dependence. The cleanest expression is to stay long the more durable infrastructure winner and fade the more cyclical one as the cycle matures. The key catalyst window is the next 2-3 quarters, when hyperscaler capex plans and memory pricing should keep sentiment constructive; the reversal window is 2027-2028, when new wafer capacity and package supply begin to normalize and the market starts pricing the next margin reset. In that regime, MRVL should compound more steadily while MU’s earnings power becomes increasingly headline-volatile.